The Glycemic Control Advanced Application provides data to help teams anticipate, prevent, detect, and manage dysglycemia (hypo- and hyperglycemia) in hospitalized patients. In-Development
- Executive dashboard that summarizes perioperative glucose measurements and outcome metrics related to glucose management
- Tab summarizing average glucose measurements, time to insulin, time to euglycemia, and incidence of hypoglycemic events
- Pre-op tab that identifies HbA1c averages for diabetes patients, identifies patients at risk for diabetes, and tracks glucose testing rates based on patient risk factors
- Additional tabs that assist in tracking hyperglycemia and hypoglycemia for surgical patients, engagement of diabetes educators
Improved glucose monitoring and insulin administration.
Increased number of patients with appropriate glucose management for the entire hospital stay.
Reduced hospital mortality and length of stay (LOS) associated with hyper- and hypoglycemia.
Glycemic control for hospitalized patients is a common challenge. Poor glucose management can contribute to increased infection risk, poor wound healing, and other serious complications. Improving glycemic control can reduce length of stay and cost per case, prevent readmissions, improve quality of life, and increase patient satisfaction. The Glycemic Control application helps hospitals track glycemic control rates and their impact on length of stay and outcomes. It also helps improvement teams track compliance to standardized protocols for glucose monitoring and insulin administration for patients in the hospital and helps identify hospitalized patients with previously undiagnosed diabetes.
It’s common knowledge that glycemic control is important, but organizations need to be able to see and measure the correlation between outcomes (infections, LOS) and improvements in glucose management. Improvement teams also need to be able to track compliance to standard measures that will improve glucose management for these patients.
- Identify the timeliness of glucose monitoring and insulin administration for appropriate patients.
- Identify potential reduction in nosocomial infections and length of stay (LOS) from improvement in glucose monitoring and insulin administration for appropriate patients.
- Increase the compliance with standardized protocol and hospital policy for glucose monitoring and insulin administration.
- Increase the percentage of patients within glucose range of 100-180 mg/dL (100-150 mg/dL for CV surgery patients) for the entire hospital stay.
- Reduce the rate of complications associated with hyper- and hypoglycemia.
- Reduce the length of stay (LOS) associated with hyper- and hypoglycemia.